Arcadia Biosciences, Inc. (RKDA) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $4.86M | -3.7% |
| 2024 | $5.04M | +13.3% |
| 2023 | $4.45M | -40.0% |
| 2022 | $7.42M | +9.4% |
| 2021 | $6.78M | -15.6% |
| 2020 | $8.03M | +587.3% |
| 2019 | $1.17M | -20.2% |
| 2018 | $1.46M | -63.6% |
| 2017 | $4.03M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $4.86M | -3.7% |
| 2024 | $5.04M | +13.3% |
| 2023 | $4.45M | -40.0% |
| 2022 | $7.42M | +9.4% |
| 2021 | $6.78M | -15.6% |
| 2020 | $8.03M | +587.3% |
| 2019 | $1.17M | -20.2% |
| 2018 | $1.46M | -63.6% |
| 2017 | $4.03M | — |